Navigation Links
Puritan Medical Products Awarded Two New Flocked Swab Patents in Japan
Date:1/7/2014

GUILFORD, Maine, Jan. 7, 2014 /PRNewswire/ -- Puritan Medical Products, the largest manufacturer of single-use specimen collection devices, has announced two new Japanese patents for their revolutionary high-performance flocked swabs.

(Photo:  http://photos.prnewswire.com/prnh/20140107/NE41287 )

The patents for the HydraFlock® swab (No. 2012-522818) and PurFlock Ultra® swab (No. 2012-522817) are the ninth and tenth international patents Puritan has received. Puritan also has device and method patents in the United States, Canada, Europe, and Australia for their line of flocked swabs, with patents pending in China.

"As our high-performance devices and proprietary methods continue to distinguish Puritan in the industry, we're expanding into a greater number of international markets," said Timothy Templet, Puritan's Executive Vice President of Global Sales. "Japan's patent awards speak to our growing recognition as one of the most trusted manufacturers of single-use medical products worldwide."

Puritan's HydraFlock® and PurFlock Ultra® swabs represent a pioneering evolution in flocked swab manufacturing technology. They are the only swabs on the market with a unique three-dimensional microstructure design resulting from specially developed fibers and a proprietary flocking process.

Multiple studies have shown HydraFlock® and PurFlock Ultra® swabs to have superior absorption capacity and more rapid specimen elution properties. The result is greater sample purity and consistency without the need for additional fiber treatments or multiple specimen collections.

HydraFlock® and PurFlock Ultra® swabs may be purchased individually, or as a part of Puritan's viral or bacterial transport systems. HydraFlock® flocked swabs, combined with Puritan's liquid amies bacterial transport systems, are uniquely engineered to provide superior performance and versatility in the collection and transport of clinically significant bacteria.

PurFlock Ultra® flocked swabs are used with Puritan's UniTranz-RT™ universal transport medium systems for the collection, preservation, and transport of viruses, chlamydia, mycoplasma, and ureaplasma specimens at room temperature (RT) or long-term freezer storage. Both kits are compatible with standard and automated laboratory equipment.

About Puritan

Puritan Medical Products Co, LLC is the largest manufacturer of single-use medical and diagnostics products in North America, producing more than 35 types of specimen collection devices including its patented flocked swabs and media-filled transport systems. All research and development, product testing, approval and release take place at Puritan's facility in Guilford, ME, U.S.A., including custom media manufacturing and compounding capability to meet a multitude of customer needs.


'/>"/>
SOURCE Puritan Medical Products
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Puritan Medical Products obtient deux nouveaux brevets en Australie pour ses écouvillons floqués
2. Puritan Medical Products erhält zwei neue Patente für beflockte Tupfer in Australien
3. Lung Cancer Alliance Congratulates 75 Medical Centers For Moving Swiftly And Responsibly On Lung Cancer Screening
4. Medical Device Developers - Network at BIOMEDevice Boston Next Week
5. Winner Medicals Special Committee Appoints Independent Financial Advisor and Retains Legal Counsel
6. Study Finds Utilizing Integrated Medical and Pharmacy Data Improves Ability to Forecast Use of High-cost Specialty Treatments
7. CareFusion to Sell Neurodiagnostic Business to Natus Medical for $58 Million
8. ulrich medical USA™ Releases New Expandable Spinal Implant for US Market
9. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
10. Essential Medical Dismisses Patent Case against Masimo and Cercacor
11. Aethlon Medical Note: An Unprecedented Data Point, The Single-Treatment Capture of Hepatitis C Virus (HCV) by the Aethlon Hemopurifier®
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/12/2017)... and Company (NYSE: LLY ) has entered into ... litigation in the U.S. District Court for the Eastern District ... (tadalafil) unit dose patent. This patent was previously set ... agreement, Cialis exclusivity is now expected to end at the ... patent for Cialis is valid and infringed by companies seeking ...
(Date:7/11/2017)... 11, 2017  The global market for liquid biopsy ... $394.1 million in 2016.  Although in early stages, the ... in particular as a result of the gradual shift ... recent introduction of a significant number of new liquid ... of tumor biomarkers to guide treatment decisions. ...
(Date:7/11/2017)... July 11, 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... pharmaceutical company focused on the development of oral drug ... Drug Administration (FDA) has agreed to schedule an End-of-Phase ... IIb trial of its oral insulin capsule ORMD-0801 in ... trial met primary and secondary endpoints by indicating a ...
Breaking Medicine Technology:
(Date:7/21/2017)... ... July 21, 2017 , ... ... students improve their chances of acceptance to a residency in a United States ... earned degrees outside the U.S. , According to data released by the ECFMG®, ...
(Date:7/21/2017)... ... July 21, 2017 , ... West Dermatology is pleased ... Vu, PA-C. Beginning July 17, 2017, Ms. Vu will join West Dermatology’s large network ... experience in dermatology, skin cancer , and more. She graduated from the University ...
(Date:7/21/2017)... ... July 21, 2017 , ... How physicians and ... the rise, say researchers presenting their work at the American Orthopaedic Society ... combination of evaluating the patterns of change in concussion symptom presentation, diagnostic tools ...
(Date:7/20/2017)... ... July 20, 2017 , ... Acute myeloid leukemia (AML) is ... rapidly without treatment. Newly diagnosed patients face intense chemotherapy regimens and a stem ... With such a challenging diagnosis that requires immediate action, patients and caregivers ...
(Date:7/20/2017)... ... ... For individuals with extended hospital stays or who are residents of nursing ... specially designed to accommodate patients with a wide range of ailments or special needs, ... has invented the patent-pending PORTABLE ARM REST, a specially designed armrest that features many ...
Breaking Medicine News(10 mins):